Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06641362 · ClinicalTrials.gov registry record
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
A clinical trial of Heart Failure and Bradycardia, sponsored by VDI Technologies.
- Recruiting
- Registry status
- 360
- Enrollment target
- 9
- Study locations
NCT06641362 is a study of Heart Failure and Bradycardia that is actively recruiting participants, run by VDI Technologies. The registered enrollment target is 360 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (82% lower). The trial reports 9 study locations across 7 states.
The verdict
NCT06641362, a study of Heart Failure and Bradycardia, is actively recruiting participants, sponsored by VDI Technologies.
- RECRUITING
- Registry status
- 360 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
Conditions Studied
Interventions
- DEVICE Ultra High Frequency Electrocardiogram (UHF-ECG)
Study Locations (9)
Arizona
- Peak Heart and Vascular - Avondale
- Banner Medical Center - Mesa
Other
- St. Anne's University Hospital - Brno
- Catherina Ziekenhuis - Eindhoven
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic - Rochester
Ohio
- Ohio State University - Columbus
Texas
- Baylor College of Medicine - Houston
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-03-18 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06641362
The ClinicalTrials.gov registry entry for NCT06641362 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (82% lower). The listed sponsor is VDI Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Ultra High Frequency Electrocardiogram (UHF-ECG) is the first listed.
NCT06641362 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Arizona, Other, Illinois.
Frequently Asked Questions
What is clinical trial NCT06641362 about?
NCT06641362 is a clinical study titled "Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)". The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
What is the current status of trial NCT06641362?
This trial is currently recruiting. The enrollment target is 360 participants. The study started on 2025-03-18. Estimated completion is 2026-05.
What conditions does trial NCT06641362 study?
This clinical trial studies the following conditions: Heart Failure, Bradycardia, Ventricular Dysfunction.
What interventions are being tested in trial NCT06641362?
The interventions under investigation include: Ultra High Frequency Electrocardiogram (UHF-ECG) (DEVICE).
Who is sponsoring clinical trial NCT06641362?
This trial is sponsored by VDI Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06641362 being conducted?
This trial has 9 study locations across Arizona, Illinois, Minnesota, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.